These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6871071)

  • 21. [The potentiating effects of azathioprine and azapropazone on the enzyme activity in experimental inflammation].
    Stojan B
    Z Rheumatol; 1976; 35(1-2):18-23. PubMed ID: 176844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Azapropazone plasma levels under simultaneous treatment with an antacid or laxative].
    Faust-Tinnefeldt G; Geissler HE; Mutschler E
    Arzneimittelforschung; 1977; 27(12):2411-4. PubMed ID: 580058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of azapropazone following single oral and intravenous doses.
    Breuing KH; Gilfrich HJ; Meinertz T; Jähnchen E
    Arzneimittelforschung; 1979; 29(6):971-2. PubMed ID: 582795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-inflammatory action of azapropazone.
    Lewis DA; Best R; Bird J
    J Pharm Pharmacol; 1977 Feb; 29(2):113-4. PubMed ID: 15057
    [No Abstract]   [Full Text] [Related]  

  • 25. The amphiprotic character of azapropazone and its relevance to the gastric mucosa.
    McCormack K; Brune K
    Arch Toxicol; 1990; 64(1):1-6. PubMed ID: 2407231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of prostaglandin potentiated formalin induced arthritis with non-steroid antiphlogistics.
    Szántó L; Tanka D; Kellner M
    Int J Clin Pharmacol Biopharm; 1976 Mar; 13(2):113-9. PubMed ID: 1254374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoglycaemia due to azapropazone-tolbutamide interaction.
    Waller DG; Waller D
    Br J Rheumatol; 1984 Feb; 23(1):24-5. PubMed ID: 6697069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenytoin-salicylate interaction.
    Leonard RF; Knott PJ; Rankin GO; Robinson DS; Melnick DE
    Clin Pharmacol Ther; 1981 Jan; 29(1):56-60. PubMed ID: 7460475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Human pharmacokinetics of different i.v. doses of azapropazone (HPLC-determination) (author's transl)].
    Gikalov I; Kaufmann R; Schuster O
    Arzneimittelforschung; 1982; 32(4):423-6. PubMed ID: 7201814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Azapropazone binding to human serum albumin.
    Fehske KJ; Jähnchen E; Müller WE; Stillbauer A
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug; 313(2):159-63. PubMed ID: 7422015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salivary phenytoin concentrations in epilepsy and in chronic renal failure.
    Reynolds F; Ziroyanis PN; Jones NF; Smith SE
    Lancet; 1976 Aug; 2(7982):384-6. PubMed ID: 73850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The determination of azapropazone and its 6-hydroxy metabolite in plasma and urine by HPLC.
    Kline BJ; Wood JH; Beightol LA
    Arzneimittelforschung; 1983; 33(4):504-6. PubMed ID: 6683526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Azapropazone and rheumatic combination therapy considering drug interactions: azapropazone aurothioglucose and azapropazone prednisolone].
    Faust-Tinnefeldt GF; Geissler HE
    Arzneimittelforschung; 1978; 28(2):337-41. PubMed ID: 346022
    [No Abstract]   [Full Text] [Related]  

  • 34. Interaction between azapropazone and warfarin.
    McElnay JC; D'Arcy PF
    Br Med J; 1977 Sep; 2(6089):773-4. PubMed ID: 912313
    [No Abstract]   [Full Text] [Related]  

  • 35. Interaction between vigabatrin and phenytoin.
    Rimmer EM; Richens A
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):27S-33S. PubMed ID: 2757906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methotrexate toxicity precipitated by azapropazone.
    Daly HM; Scott GL; Boyle J; Roberts CJ
    Br J Dermatol; 1986 Jun; 114(6):733-5. PubMed ID: 3718865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of heparin or salicylate infusion on serum protein binding and on concentrations of phenytoin in serum, brain and cerebrospinal fluid of rats.
    Chou RC; Levy G
    J Pharmacol Exp Ther; 1981 Oct; 219(1):42-8. PubMed ID: 7288614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of aspirin on salivary and serum phenytoin kinetics in healthy subjects.
    Paxton JW
    Clin Pharmacol Ther; 1980 Feb; 27(2):170-8. PubMed ID: 7353335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma protein binding and metabolic clearance of phenytoin in the rat.
    Colburn WA; Gibaldi M
    J Pharmacol Exp Ther; 1977 Dec; 203(3):500-6. PubMed ID: 925955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma protein binding interaction between phenytoin and valproic acid in vitro.
    Monks A; Boobis S; Wadsworth J; Richens A
    Br J Clin Pharmacol; 1978 Dec; 6(6):487-92. PubMed ID: 365209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.